These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26554871)

  • 1. Congenital thrombocytopenia in a neonate with an interstitial microdeletion of 3q26.2q26.31.
    Bouman A; Knegt L; Gröschel S; Erpelinck C; Sanders M; Delwel R; Kuijpers T; Cobben JM
    Am J Med Genet A; 2016 Feb; 170A(2):504-509. PubMed ID: 26554871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital hypoplastic bone marrow failure associated with a de novo partial deletion of the MECOM gene at 3q26.2.
    Kjeldsen E; Veigaard C; Aggerholm A; Hasle H
    Gene; 2018 May; 656():86-94. PubMed ID: 29496554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of the 3q26 region including the EVI1 and MDS1 genes in a neonate with congenital thrombocytopenia and subsequent aplastic anaemia.
    Nielsen M; Vermont CL; Aten E; Ruivenkamp CA; van Herrewegen F; Santen GW; Breuning MH
    J Med Genet; 2012 Sep; 49(9):598-600. PubMed ID: 22972950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer.
    Nanjundan M; Nakayama Y; Cheng KW; Lahad J; Liu J; Lu K; Kuo WL; Smith-McCune K; Fishman D; Gray JW; Mills GB
    Cancer Res; 2007 Apr; 67(7):3074-84. PubMed ID: 17409414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in MECOM, Encoding Oncoprotein EVI1, Cause Radioulnar Synostosis with Amegakaryocytic Thrombocytopenia.
    Niihori T; Ouchi-Uchiyama M; Sasahara Y; Kaneko T; Hashii Y; Irie M; Sato A; Saito-Nanjo Y; Funayama R; Nagashima T; Inoue S; Nakayama K; Ozono K; Kure S; Matsubara Y; Imaizumi M; Aoki Y
    Am J Hum Genet; 2015 Dec; 97(6):848-54. PubMed ID: 26581901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia.
    Ottema S; Mulet-Lazaro R; Beverloo HB; Erpelinck C; van Herk S; van der Helm R; Havermans M; Grob T; Valk PJM; Bindels E; Haferlach T; Haferlach C; Smeenk L; Delwel R
    Blood; 2020 Jul; 136(2):224-234. PubMed ID: 32219447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EVI1, a target gene for amplification at 3q26, antagonizes transforming growth factor-β-mediated growth inhibition in hepatocellular carcinoma.
    Yasui K; Konishi C; Gen Y; Endo M; Dohi O; Tomie A; Kitaichi T; Yamada N; Iwai N; Nishikawa T; Yamaguchi K; Moriguchi M; Sumida Y; Mitsuyoshi H; Tanaka S; Arii S; Itoh Y
    Cancer Sci; 2015 Jul; 106(7):929-37. PubMed ID: 25959919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator.
    Soderholm J; Kobayashi H; Mathieu C; Rowley JD; Nucifora G
    Leukemia; 1997 Mar; 11(3):352-8. PubMed ID: 9067573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated.
    Lugthart S; van Drunen E; van Norden Y; van Hoven A; Erpelinck CA; Valk PJ; Beverloo HB; Löwenberg B; Delwel R
    Blood; 2008 Apr; 111(8):4329-37. PubMed ID: 18272813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification and translocation of 3q26 with overexpression of EVI1 in Fanconi anemia-derived childhood acute myeloid leukemia with biallelic FANCD1/BRCA2 disruption.
    Meyer S; Fergusson WD; Whetton AD; Moreira-Leite F; Pepper SD; Miller C; Saunders EK; White DJ; Will AM; Eden T; Ikeda H; Ullmann R; Tuerkmen S; Gerlach A; Klopocki E; Tönnies H
    Genes Chromosomes Cancer; 2007 Apr; 46(4):359-72. PubMed ID: 17243162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EVI1 is consistently expressed as principal transcript in common and rare recurrent 3q26 rearrangements.
    Poppe B; Dastugue N; Vandesompele J; Cauwelier B; De Smet B; Yigit N; De Paepe A; Cervera J; Recher C; De Mas V; Hagemeijer A; Speleman F
    Genes Chromosomes Cancer; 2006 Apr; 45(4):349-56. PubMed ID: 16342172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities.
    Baldazzi C; Luatti S; Zuffa E; Papayannidis C; Ottaviani E; Marzocchi G; Ameli G; Bardi MA; Bonaldi L; Paolini R; Gurrieri C; Rigolin GM; Cuneo A; Martinelli G; Cavo M; Testoni N
    Genes Chromosomes Cancer; 2016 Apr; 55(4):375-88. PubMed ID: 26815134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forced expression of the leukemia-associated gene EVI1 in ES cells: a model for myeloid leukemia with 3q26 rearrangements.
    Sitailo S; Sood R; Barton K; Nucifora G
    Leukemia; 1999 Nov; 13(11):1639-45. PubMed ID: 10557037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intergenic splicing of MDS1 and EVI1 occurs in normal tissues as well as in myeloid leukemia and produces a new member of the PR domain family.
    Fears S; Mathieu C; Zeleznik-Le N; Huang S; Rowley JD; Nucifora G
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1642-7. PubMed ID: 8643684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EVI1 splice variants modulate functional responses in ovarian cancer cells.
    Dutta P; Bui T; Bauckman KA; Keyomarsi K; Mills GB; Nanjundan M
    Mol Oncol; 2013 Jun; 7(3):647-68. PubMed ID: 23517670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rearrangement of the AML1/CBFA2 gene in myeloid leukemia with the 3;21 translocation: expression of co-existing multiple chimeric genes with similar functions as transcriptional repressors, but with opposite tumorigenic properties.
    Zent C; Kim N; Hiebert S; Zhang DE; Tenen DG; Rowley JD; Nucifora G
    Curr Top Microbiol Immunol; 1996; 211():243-52. PubMed ID: 8585955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of sequences telomeric of the EVI1 gene in 3q26 associated with a novel pericentric inv(3)(p25q26) in a patient with acute myelogenous leukemia.
    Wieser R; Lechner K; Valent P; Fonatsch C
    Haematologica; 2003 Dec; 88(12):1427-9. PubMed ID: 14688000
    [No Abstract]   [Full Text] [Related]  

  • 18. Fanconi anemia (FA)-associated 3q gains in leukemic transformation consistently target EVI1, but do not affect low TERC expression in FA.
    Meyer S; Bristow C; Wappett M; Pepper S; Whetton AD; Hanenberg H; Neitzel H; Wlodarski MW; Ebell W; Tönnies H
    Blood; 2011 Jun; 117(22):6047-50. PubMed ID: 21636719
    [No Abstract]   [Full Text] [Related]  

  • 19. Mice carrying a hypomorphic Evi1 allele are embryonic viable but exhibit severe congenital heart defects.
    Bard-Chapeau EA; Szumska D; Jacob B; Chua BQ; Chatterjee GC; Zhang Y; Ward JM; Urun F; Kinameri E; Vincent SD; Ahmed S; Bhattacharya S; Osato M; Perkins AS; Moore AW; Jenkins NA; Copeland NG
    PLoS One; 2014; 9(2):e89397. PubMed ID: 24586749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute panmyelosis with myelofibrosis with EVI1 amplification.
    Grygalewicz B; Woroniecka R; Pastwińska A; Rygier J; Krawczyk P; Borg K; Makuch-Łasica H; Patkowska E; Pieńkowska-Grela B
    Cancer Genet; 2012 May; 205(5):255-60. PubMed ID: 22682625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.